$13.36
00.00%
Pre-Market: Jul 19, 5:07 PM EDT
15 minutes delayed
Comments
Loading...
Takeda Pharmaceutical
TAKNYSE
Takeda Pharmaceutical (NYSE:TAK) Stock, Earnings Estimates, EPS, And Revenue
Takeda Pharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS
$0.240
Quarterly Revenue
$7.1B
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$4.3T
Analyze the earnings history of Takeda Pharmaceutical using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TAK | Takeda Pharmaceutical | $0.40 | — | — | — | $7.33B | — | — | — | 07/31/2024 | Get Alert |
| TAK | Takeda Pharmaceutical | $0.39 | — | $0.24 | — | $7.23B | — | $7.08B | — | 05/09/2024 | Get Alert |
| TAK | Takeda Pharmaceutical | $0.59 | — | $0.51 | — | $9.65B | — | $7.88B | — | 02/01/2024 | Get Alert |
| TAK | Takeda Pharmaceutical | $0.52 | — | $0.48 | — | $7.26B | — | $6.34B | — | 10/26/2023 | Get Alert |
| TAK | Takeda Pharmaceutical | $0.56 | — | $0.52 | — | $7.51B | — | $7.33B | — | 07/27/2023 | Get Alert |
| TAK | Takeda Pharmaceutical | $0.40 | — | $0.39 | — | $7.52B | — | $7.23B | — | 05/11/2023 | Get Alert |
| TAK | Takeda Pharmaceutical | — | — | $0.59 | — | $7.93B | — | $9.65B | — | 02/02/2023 | Get Alert |
| TAK | Takeda Pharmaceutical | $0.45 | — | $0.52 | — | $7.69B | — | $7.26B | — | 10/27/2022 | Get Alert |
| TAK | Takeda Pharmaceutical | $0.52 | — | $0.56 | — | $8.64B | — | $7.51B | — | 07/28/2022 | Get Alert |
| TAK | Takeda Pharmaceutical | $0.41 | — | $0.40 | — | $7.24B | — | $7.52B | — | 05/11/2022 | Get Alert |
| TAK | Takeda Pharmaceutical | $0.54 | — | $0.52 | — | $8.01B | — | $7.93B | — | 02/03/2022 | Get Alert |
| TAK | Takeda Pharmaceutical | $0.47 | — | $0.45 | — | $7.47B | — | $7.69B | — | 10/28/2021 | Get Alert |
| TAK | Takeda Pharmaceutical | $0.57 | — | $0.52 | — | $7.46B | — | $8.64B | — | 07/30/2021 | Get Alert |
| TAK | Takeda Pharmaceutical | $0.12 | — | $0.41 | — | $7.08B | — | $7.24B | — | 05/11/2021 | Get Alert |
| TAK | Takeda Pharmaceutical | $0.53 | — | $0.54 | — | $7.91B | — | $8.01B | — | 02/04/2021 | Get Alert |
| TAK | Takeda Pharmaceutical | $0.54 | $0.98 | $0.47 | -52.04% | $7.50B | $7.56M | $7.47B | 98722.75% | 10/29/2020 | Get Alert |
| TAK | Takeda Pharmaceutical | $0.58 | — | $0.57 | — | $7.82B | — | $7.46B | — | 07/31/2020 | Get Alert |
| TAK | Takeda Pharmaceutical | $0.17 | $0.43 | $0.12 | -72.09% | $6.60B | $7.48M | $7.08B | 94539.04% | 05/13/2020 | Get Alert |
| TAK | Takeda Pharmaceutical | — | $0.32 | $0.53 | 65.62% | — | $8.14M | $7.91B | 97025.31% | 02/04/2020 | Get Alert |
| TAK | Takeda Pharmaceutical | — | — | $0.54 | — | — | — | $7.50B | — | 10/31/2019 | Get Alert |
| TAK | Takeda Pharmaceutical | — | — | $0.58 | — | — | — | $7.82B | — | 07/31/2019 | Get Alert |
Takeda Pharmaceutical (TAK) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2020 | 2020-10-29 | $0.47 | $0.98 | -52.0 % |
| Mar 2020 | 2020-05-13 | $0.12 | $0.43 | -72.1 % |
| Dec 2019 | 2020-02-04 | $0.53 | $0.32 | 65.6 % |
Takeda Pharmaceutical (TAK) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2020 | 2020-10-29 | $7.47B | $7.56M | 98722.8 % |
| Mar 2020 | 2020-05-13 | $7.08B | $7.48M | 94539.0 % |
| Dec 2019 | 2020-02-04 | $7.91B | $8.14M | 97025.3 % |
FAQ
When is Takeda Pharmaceutical (NYSE:TAK) reporting earnings?
Takeda Pharmaceutical (TAK) is scheduled to report earnings on July 31, 2024. The last reported earnings were for reported on May 9, 2024 for Q4.
What were the latest earnings per share (EPS) for Takeda Pharmaceutical (NYSE:TAK)?
The Actual EPS was $0.24, which beat the estimate of $0.00.
What were Takeda Pharmaceutical’s (NYSE:TAK) revenues?
The Actual Revenue was $7.1B, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.